2seventy bio, Inc. focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
| Market Cap | 91.846 Million | Shares Outstanding | 50.465 Million | Avg 30-day Volume | 2.066 Million |
| P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.76 |
| Price to Revenue | 3.5026 | Debt to Equity | 0.0 | EBITDA | -178.68 Million |
| Price to Book Value | 1.4035 | Operating Margin | -132.6171 | Enterprise Value | 171.63 Million |
| Current Ratio | 4.988 | EPS Growth | 0.63 | Quick Ratio | 4.887 |
| 1 Yr BETA | 1.3829 | 52-week High/Low | 16.17 / 1.54 | Profit Margin | -122.3274 |
| Operating Cash Flow Growth | 9.8639 | Free Cash Flow to Firm (FCFF) TTM | -179.63 Million | Free Cash Flow to Equity (FCFE) TTM | -163.333 Million |
| Altman Z-Score | -0.0606 |
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
GREGORY PHILIP D CHIEF SCIENTIFIC OFFICER |
|
257,250 | 2023-08-22 | 5 |
|
BAIRD WILLIAM D III CHIEF FINANCIAL OFFICER |
|
196,366 | 2023-08-22 | 6 |
|
LESCHLY NICK PRESIDENT AND CEO |
|
1,215,575 | 2023-08-22 | 6 |
|
10,580,522 | 2023-08-10 | 2 | |
|
KYNAM GLOBAL HEALTHCARE MASTER FUND, LP KYNAM FUND GP, LLC KYNAM CAPITAL MANAGEMENT GP, LLC |
|
10,580,522 | 2023-08-10 | 2 |
|
21,053 | 2023-06-13 | 1 | |
|
15,602 | 2023-06-13 | 1 | |
|
19,050 | 2023-06-13 | 1 | |
|
19,510 | 2023-06-13 | 1 | |
|
20,800 | 2023-06-13 | 3 | |
|
15,602 | 2023-06-13 | 1 | |
|
HEFFRON NICOLA CHIEF OPERATING OFFICER |
|
89,182 | 2023-02-07 | 4 |
|
10,249 | 2021-11-11 | 0 | |
|
0 | 2021-11-03 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|---|---|---|---|
| 2SEVENTY BIO INC TSVT | 2023-11-28 22:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 21:45:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 21:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 20:45:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 20:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 19:45:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 19:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 18:45:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 18:15:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 17:45:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 17:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 16:45:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 16:15:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 15:45:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 15:15:03 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 14:45:04 UTC | 4.6967 | 0.6233 | 1400000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 14:15:04 UTC | 4.6967 | 0.6233 | 1100000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 13:45:04 UTC | 4.714 | 0.606 | 1000000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 13:15:03 UTC | 4.714 | 0.606 | 1000000 |
| 2SEVENTY BIO INC TSVT | 2023-11-28 12:45:04 UTC | 4.714 | 0.606 | 1000000 |
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|---|---|---|---|
| Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | TSVT | -1300.0 shares, $-5096.0 | 2023-09-30 | N-PORT |
